Xiaoxu Li, Liying Chen, Zhaoyang Yan, Tongxin Xu, Yan Zhao. Triptonide suppresses the FOXK1/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma. // Genes & Genomics. – 2025. – DOI: 10.1007/s13258-025-01701-3. – URL: https://doi.org/10.1007/s13258-025-01701-3
Xiaoxu Li, Liying Chen, Zhaoyang Yan, Tongxin Xu, & Yan Zhao (2025). Triptonide suppresses the FOXK1/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma. Genes & Genomics. https://doi.org/10.1007/s13258-025-01701-3
Xiaoxu Li, et al. “Triptonide suppresses the FOXK1/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma.” Genes & Genomics, 2025. doi:10.1007/s13258-025-01701-3.
@article{Li2025,
title = {Triptonide suppresses the FOXK1/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma},
author = {Li, Xiaoxu and Chen, Liying and Yan, Zhaoyang and Xu, Tongxin and Zhao, Yan},
journal = {Genes \& Genomics},
year = {2025},
doi = {10.1007/s13258-025-01701-3},
url = {https://doi.org/10.1007/s13258-025-01701-3}
}